Halozyme Therapeutics
HALO
#2006
Rank
S$10.38 B
Marketcap
$81.99
Share price
1.04%
Change (1 day)
53.33%
Change (1 year)

Halozyme Therapeutics (HALO) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : S$2.18 B

According to Halozyme Therapeutics's latest financial reports the company's total liabilities are S$2.18 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Halozyme Therapeutics - Total liabilities on balance sheet (from 2002 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$2.17 B-2.8%
2022-12-31S$2.24 B83.12%
2021-12-31S$1.22 B115.84%
2020-12-31S$0.56 B-11.07%
2019-12-31S$0.63 B144.57%
2018-12-31S$0.26 B-37.45%
2017-12-31S$0.41 B-2.06%
2016-12-31S$0.42 B116.54%
2015-12-31S$0.19 B19.33%
2014-12-31S$0.16 B6.7%
2013-12-31S$0.15 B46.85%
2012-12-31S$0.10 B47.91%
2011-12-31S$71.04 M-22.35%
2010-12-31S$91.48 M-7.32%
2009-12-31S$98.71 M12.2%
2008-12-31S$87.98 M33.17%
2007-12-31S$66.06 M87.24%
2006-12-31S$35.28 M820.02%
2005-12-31S$3.83 M64.67%
2004-12-31S$2.32 M400.44%
2003-12-31S$0.46 M-56.04%
2002-12-31S$1.05 M17287.99%
2001-12-31S$0 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$0.87 B-60.14%๐Ÿ‡บ๐Ÿ‡ธ USA
S$75.85 B 3,366.56%๐Ÿ‡บ๐Ÿ‡ธ USA
S$24.23 B 1,007.36%๐Ÿ‡บ๐Ÿ‡ธ USA
S$167.00 B 7,531.89%๐Ÿ‡บ๐Ÿ‡ธ USA
S$79.25 B 3,521.58%๐Ÿ‡ซ๐Ÿ‡ท France
S$142.69 B 6,420.72%๐Ÿ‡บ๐Ÿ‡ธ USA